ArticleFrontiers in public health2024

Trends of the second measles vaccine (MCV2) over time after its launch as part of routine immunization in Nigeria: a brief research report.

Ryoko SatoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.